TARDBP and amyotrophic lateral sclerosis: Interestingly, inhibition of Prmt1 function also prevents Oxr1-C from significantly decreasing cytoplasmic aggregation of wild-type and ALS mutant Fus and Tdp-43 whose binding with Oxr1-C is not affected (Fig. 5E).